Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Stem Cells and Gene Therapy in Progressive Hearing Loss: the State of the Art

Journal of the Association for Research in Otolaryngology(2021)10.1007/s10162-020-00781-0Source: DataRank Database

Stem Cells and Gene Therapy in Progressive Hearing Loss: the State of the Art is a research paper published in Journal of the Association for Research in Otolaryngology (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 1.64)OA: hybridTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Brett Colbert ORCID,Eric S. Nisenbaum ORCID,A. Amraoui ORCID,Derek M. Dykxhoorn ORCID,Karl R. Koehler ORCID

Live enrichment

PubMed:33507440 PMC:PMC7943682 OpenAlex:https://openalex.org/W3123627446

National Institutes of Health

Grant: R01DC005575

National Institutes of Health

Grant: R01DC012115

National Institutes of Health

Grant: R01DC107624

National Institutes of Health

Grant: T32 DC015995

Agence Nationale de la Recherche

Grant: ANR-15-RHUS-0001

NIGMS NIH HHS

Grant: T32 GM112601

National Institutes of Health

Grant: 5R01DC005575-09

Molecular Genetics of Non-Syndromic Deafness

French National Research Agency (ANR)

Grant: ANR-17-CE16-0017

LATE ONSET HEARING IMPAIRMENT: FROM DISEASE MECHANISMS TO THERAPY

National Institutes of Health

Grant: 5T32DC015995-02

Interdisciplinary Research Training in Otolaryngology

National Institutes of Health

Grant: 2R01DC012115-06A1

Implementing genomic medicine in clinical care of deaf patients

FWCI

1.64

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s10162-020-00781-0.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10162-020-00781-0.pdf

publisherhttp://link.springer.com/content/pdf/10.1007/s10162-020-00781-0.pdf

publisherhttp://link.springer.com/article/10.1007/s10162-020-00781-0/fulltext.html

journalhttps://doi.org/10.1007/s10162-020-00781-0

Fields of Study

Retinal Development and DisordersHearing, Cochlea, Tinnitus, GeneticsCRISPR and Genetic Engineering0301 basic medicine03 medical and health sciencesGenetic TherapyHearing LossHumansInduced Pluripotent Stem CellsQuality of LifeStem Cell Transplantation

MeSH Terms

HumansQuality of LifeGenetic TherapyStem Cell TransplantationHearing LossInduced Pluripotent Stem Cells

Keywords

Hearing lossInduced pluripotent stem cellSensorineural hearing lossGenetic enhancementGenome editingMedicineSensory lossAudiologyGeneBiologyBioinformaticsNeuroscienceGeneticsEmbryonic stem cellGenomeGene therapyOtotoxicityInduced Pluripotent Stem CellsPresbycusisAutosomal Dominant Hearing LossReview ArticleGenetic Therapy[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansQuality of LifeHumansStem Cell Transplantation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Stem Cells and Gene Therapy in Progressive Hearing Loss: the State of the Art

FAIR Checklist

Authors (8)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)